<DOC>
	<DOCNO>NCT00359138</DOCNO>
	<brief_summary>This randomize , double-blind , double-dummy , placebo-controlled , parallel-group , single center study subject positive histamine skin prick test positive RadioAllergoSorbent Test ( RAST ) ( class &gt; 2 ) one test standardized allergenic extract : tree pollen , cat dander , house dust mite , mixture five grass pollen . Subjects randomize desloratadine 5 mg daily , levocetirizine 5mg daily , placebo daily 8 day treatment follow 11 day skin test discontinuation antihistamine treatment phase . The duration suppressive effect desloratadine cutaneous allergen-induced wheal flare responses discontinuation one-week treatment establish .</brief_summary>
	<brief_title>The Duration Suppressive Effects Desloratadine Allergen Prick Tests After Discontinuation ( P04441 )</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Subjects must 18 year age old , either sex . Subjects must least history positive skin test allergen tree pollen , grass pollen , house dust mite , cat dander . Non symptomatic volunteer allergic different pollen must include specific pollinic season . Subjects must demonstrate willingness participate study comply procedure sign write informed consent . Subjects must understand able adhere visit schedule Subjects must general good health . Women childbearing potential must negative pregnancy test Day 1 must use accepted method contraception entire duration study . Subjects persistent asthma . Subjects chronic urticaria atopic dermatosis . Subjects receive treatment list recently indicate washout period prior Randomization , must continue receive treatment list . Medications Prohibited During Trial Washout Period Prior Visit 1 Corticosteroids Intramuscular intraarticular , 1 month Oral , inhale , intravenous , rectal , intranasal , ocular , 7 day Highpotency dermatological , 7 day Cromolyn/Lodoxamide/Nedocromil Intranasal , ocular , inhaled , oral , 2 day Antihistamines Longacting prescription ( eg , levocetirizine , fexofenadine , desloratadine ) , 15 day Shortacting ( eg , chlorpheniramine , brompheniramine include overthecounter [ OTC ] form , hydroxyzine ) , 15 day Ocular ( eg , levocabastine ) , 15 day Leukotriene inhibitor ( eg , montelukast ) , 7 day Systemic antibiotic , 14 day ( washout refers antibiotic use treat upper low respiratory tract infection ) Immunotherapy ( desensitization ) , 1 year Decongestants oral , 2 day local , 2 day Ophthalmic nonsteroidal antiinflammatory drug ( NSAIDs ; eg , Toradol ) , 5 day Investigational medication , 30 day Tricyclic antidepressant ( eg , amitriptyline , clomipramine , doxepin , imipramine , trimipramine , amoxapine , desipramine , nortriptyline , protriptyline ) , 30 day Tetracyclic antidepressant ( eg , maprotiline , mirtazapine ) , 30 day Subjects history hypersensitivity desloratadine , levocetirizine , excipients . Women breastfeed , pregnant , intend become pregnant . Subjects clinically significant condition situation , condition study , , opinion investigator , would interfere study evaluation optimal participation study . Subjects use investigational drug within 30 day randomization . Subjects work 11 PM 8 AM ( night shift ) . Subjects skin/color pigmentation incompatible accurate measurement flare reaction . Subjects cutaneous hyperactivity : negative prick test control &gt; 3 mm . Subjects participate clinical study . Subjects part staff personnel directly involve study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Histamine H1 Antagonists</keyword>
	<keyword>Anti-Allergic Agents</keyword>
</DOC>